239 related articles for article (PubMed ID: 31077615)
1. Circulating long non-coding RNA GAS5 and SOX2OT as potential biomarkers for diagnosis and prognosis of non-small cell lung cancer.
Kamel LM; Atef DM; Mackawy AMH; Shalaby SM; Abdelraheim N
Biotechnol Appl Biochem; 2019 Jul; 66(4):634-642. PubMed ID: 31077615
[TBL] [Abstract][Full Text] [Related]
2. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
[TBL] [Abstract][Full Text] [Related]
3. Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer.
Liang W; Lv T; Shi X; Liu H; Zhu Q; Zeng J; Yang W; Yin J; Song Y
Medicine (Baltimore); 2016 Sep; 95(37):e4608. PubMed ID: 27631209
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived exosomal lncRNA GAS5 as a biomarker for early-stage non-small-cell lung cancer diagnosis.
Li C; Lv Y; Shao C; Chen C; Zhang T; Wei Y; Fan H; Lv T; Liu H; Song Y
J Cell Physiol; 2019 Nov; 234(11):20721-20727. PubMed ID: 31032916
[TBL] [Abstract][Full Text] [Related]
5. Identification of circulating long non-coding RNA GAS5 as a potential biomarker for non-small cell lung cancer diagnosisnon-small cell lung cancer, long non-coding RNA, plasma, GAS5, biomarker.
Tan Q; Zuo J; Qiu S; Yu Y; Zhou H; Li N; Wang H; Liang C; Yu M; Tu J
Int J Oncol; 2017 May; 50(5):1729-1738. PubMed ID: 28339045
[TBL] [Abstract][Full Text] [Related]
6. Circulating Long Non-Coding RNA GAS5: A Non-Invasive Molecular Marker for Prognosis, Response to Treatment and Survival in Non-Small Cell Lung Cancer.
Al Mourgi M; El Askary A; Gharib AF; Alzahrani R; Banjer HJ; Elsawy WH; Al Ghamdi AE; Raafat N
Cancer Invest; 2021; 39(6-7):505-513. PubMed ID: 33969786
[TBL] [Abstract][Full Text] [Related]
7. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer.
Peng H; Wang J; Li J; Zhao M; Huang SK; Gu YY; Li Y; Sun XJ; Yang L; Luo Q; Huang CZ
Life Sci; 2016 Apr; 151():235-242. PubMed ID: 26946307
[TBL] [Abstract][Full Text] [Related]
8. Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer.
Tao Y; Tang Y; Yang Z; Wu F; Wang L; Yang L; Lei L; Jing Y; Jiang X; Jin H; Bai Y; Zhang L
Int J Biol Sci; 2020; 16(3):471-482. PubMed ID: 32015683
[TBL] [Abstract][Full Text] [Related]
9. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer.
Tantai J; Hu D; Yang Y; Geng J
Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353
[TBL] [Abstract][Full Text] [Related]
10. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer.
Li W; Li N; Kang X; Shi K
Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690
[TBL] [Abstract][Full Text] [Related]
11. Increased serum exosomal long non-coding RNA SNHG15 expression predicts poor prognosis in non-small cell lung cancer.
Han P; Zhao J; Gao L
J Clin Lab Anal; 2021 Nov; 35(11):e23979. PubMed ID: 34551140
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the non-coding SOX2OT variants 4 and 7 in lung tumors suggests an oncogenic role in lung cancer.
Saghaeian Jazi M; Samaei NM; Ghanei M; Shadmehr MB; Mowla SJ
Tumour Biol; 2016 Aug; 37(8):10329-38. PubMed ID: 26846097
[TBL] [Abstract][Full Text] [Related]
13. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer.
Shi X; Sun M; Liu H; Yao Y; Kong R; Chen F; Song Y
Mol Carcinog; 2015 Jun; 54 Suppl 1():E1-E12. PubMed ID: 24357161
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer.
Wu Y; Lyu H; Liu H; Shi X; Song Y; Liu B
Sci Rep; 2016 Aug; 6():31093. PubMed ID: 27489122
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer.
Peng W; Wang J; Shan B; Peng Z; Dong Y; Shi W; He D; Cheng Y; Zhao W; Zhang C; Li B; Duan C
Cell Physiol Biochem; 2018; 49(2):816-827. PubMed ID: 30165346
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
17. The plasma lncRNA acting as fingerprint in non-small-cell lung cancer.
Hu X; Bao J; Wang Z; Zhang Z; Gu P; Tao F; Cui D; Jiang W
Tumour Biol; 2016 Mar; 37(3):3497-504. PubMed ID: 26453113
[TBL] [Abstract][Full Text] [Related]
18. Three circulating long non-coding RNAs act as biomarkers for predicting NSCLC.
Tang Q; Ni Z; Cheng Z; Xu J; Yu H; Yin P
Cell Physiol Biochem; 2015; 37(3):1002-9. PubMed ID: 26393913
[TBL] [Abstract][Full Text] [Related]
19. A long noncoding RNA Sox2ot regulates lung cancer cell proliferation and is a prognostic indicator of poor survival.
Hou Z; Zhao W; Zhou J; Shen L; Zhan P; Xu C; Chang C; Bi H; Zou J; Yao X; Huang R; Yu L; Yan J
Int J Biochem Cell Biol; 2014 Aug; 53():380-8. PubMed ID: 24927902
[TBL] [Abstract][Full Text] [Related]
20. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
